Search Results 431-440 of 16806 for GLP-1 agonists
This is a safety and pharmacokinetics study of MK-4280 as monotherapy and in combination with pembrolizumab (MK-3475) in adults with metastatic solid tumors for ...
A nurse or other trained health professional will give you this medicine. It is given through a needle placed into one of your veins. It must be given slowly, ...
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1 · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...
Tired of failed fad diets? Maybe it's time for a change. The Mayo Clinic Diet is a different approach to weight loss. First, the Mayo Clinic Diet is based on ...
The purpose of this study is to evaluate SV-BR-1-GM in metastatic or locally recurrent breast cancer patients, in combination with the PD-1 inhibitor ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ... If previously on anti-diabetic medication, should be off for at least 1 month.
- To evaluate the pharmacokinetic (PK) profile of Isatuximab in the proposed dosing schedule(s). - To assess the pharmacodynamics (PD), immune response, and ...
The purpose of this study is to investigate the safety and tolerability of two dose regimens of IFX-1 as add-on to standard of care (SOC) in subjects with ...
For oral dosage form (tablets):. For treatment of HIV infection: Adults and children weighing 25 kilograms (kg) or more—One tablet once a day. Each tablet ...
Almost one-fifth of adolescents in the United States are obese and approximately 7 percent have severe obesity — defined as a body mass index (BMI) either ≥ ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!